Your browser doesn't support javascript.
loading
Do Nonsuicidal Severely Depressed Individuals with Diabetes Profit from Internet-Based Guided Self-Help? Secondary Analyses of a Pragmatic Randomized Trial.
Schlicker, Sandra; Weisel, Kiona K; Buntrock, Claudia; Berking, Matthias; Nobis, Stephanie; Lehr, Dirk; Baumeister, Harald; Snoek, Frank J; Riper, Heleen; Ebert, David D.
Afiliación
  • Schlicker S; Friedrich-Alexander University Erlangen-Nürnberg, Germany.
  • Weisel KK; Philipps-University Marburg, Germany.
  • Buntrock C; Friedrich-Alexander University Erlangen-Nürnberg, Germany.
  • Berking M; Friedrich-Alexander University Erlangen-Nürnberg, Germany.
  • Nobis S; Friedrich-Alexander University Erlangen-Nürnberg, Germany.
  • Lehr D; GET.ON Institute GmbH, Germany.
  • Baumeister H; Leuphana University Lüneburg, Germany.
  • Snoek FJ; Ulm University, Germany.
  • Riper H; VU University, Amsterdam, Netherlands.
  • Ebert DD; VU University, Amsterdam, Netherlands.
J Diabetes Res ; 2019: 2634094, 2019.
Article en En | MEDLINE | ID: mdl-31218230
ABSTRACT

INTRODUCTION:

Diabetes mellitus type 1 and type 2 are linked to higher prevalence and occurrences of depression. Internet-based depression- and diabetes-specific cognitive behavioral therapies (CBT) can be effective in reducing depressive symptom severity and diabetes-related emotional distress. The aim of the study was to test whether disease-specific severity indicators moderate the treatment outcome in a 6-week minimally guided web-based self-help intervention on depression and diabetes (GET.ON Mood Enhancer Diabetes (GET.ON M.E.D.)) and to determine its effectiveness in a nonsuicidal severely depressed subgroup.

METHODS:

Randomized controlled trial- (RCT-) based data (N = 253) comparing GET.ON M.E.D. to an online psychoeducation control group was used to test disease-specific severity indicators as predictors/moderators of a treatment outcome. Changes in depressive symptom severity and treatment response were examined in a nonsuicidal severely depressed subgroup (CES - D > 40; N = 40).

RESULTS:

Major depressive disorder diagnosis at the baseline (p prf6 = 0.01), higher levels of depression (Beck Depression Inventory II; p prpo = 0.00; p prf6 = 0.00), and lower HbA1c (p prpo = 0.04) predicted changes in depressive symptoms. No severity indicator moderated the treatment outcome. Severely depressed participants in the intervention group showed a significantly greater reduction in depressive symptom severity (d prpo = 2.17, 95% Confidence Interval (CI) 1.39-2.96) than the control condition (d prpo = 0.92; 95% CI 0.001-1.83), with a between-group effect size of d prpo = 1.05 (95% CI 0.11-1.98). Treatment response was seen in significantly more participants in the intervention (4/20; 20%) compared to the control group (0/20, 0%; χ 2 (2)(N = 40) = 4.44; p < 0.02). At the 6-month follow-up, effects were maintained for depressive symptom reduction (d pr6f = 0.71; 95% CI 0.19-1.61) but not treatment response.

CONCLUSION:

Disease-specific severity indicators were not related to a differential effectiveness of guided self-help for depression and diabetes. Clinical meaningful effects were observed in nonsuicidal severely depressed individuals, who do not need to be excluded from web-based guided self-help. However, participants should be closely monitored and referred to other treatment modalities in case of nonresponse.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autocuidado / Grupos de Autoayuda / Internet / Trastorno Depresivo Mayor / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Diabetes Res Año: 2019 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autocuidado / Grupos de Autoayuda / Internet / Trastorno Depresivo Mayor / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Diabetes Res Año: 2019 Tipo del documento: Article País de afiliación: Alemania